Skip to main navigation Skip to search Skip to main content

Enhancing the invasive traits of breast cancers by CYP1B1 via regulation of p53 to promote uPAR expression

  • Yeo Jung Kwon
  • , Tae Uk Kwon
  • , Sangyun Shin
  • , Boyoung Lee
  • , Hyein Lee
  • , Hyemin Park
  • , Donghak Kim
  • , Aree Moon
  • , Young Jin Chun
  • Chung-Ang University
  • Duksung Women's University

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Human cytochrome P450 1B1 (CYP1B1) catalyzes estrogen metabolism to produce metabolites that promote the progression of breast cancer. Since the invasive properties of cancer cells cause cancer relapse, which dramatically reduces patient survival, we investigated the new pro-invasive mechanism involving CYP1B1 in breast cancer. Exploring clinical data from invasive breast cancer patients revealed that CYP1B1 exhibits a potential correlation with urokinase-type plasminogen activator receptor (uPAR). Interestingly, uPAR mRNA expression was elevated in invasive breast cancer patients carrying TP53 genes with driver mutations, and our results showed that CYP1B1 activates the uPAR pathway following regulation of p53 according to its mutant status. CYP1B1 suppressed wild-type (WT) p53 whereas it induced the oncogenic gain-of-function mutant p53R280K, not only via transcriptional regulation but also the protein stabilization and activation following phosphorylation on Ser15 residue of p53R280K. Intriguingly, results from CYP1B1 polymorphic gene study and 4-hydroxyestradiol (4-OHE2) treatment showed that CYP1B1 regulates p53s and uPAR through its enzymatic activity. Furthermore, effects of DMBA and TMS on uPAR expression disappeared in HCT116p53−/− cells, indicating that p53 is critical for uPAR induction by CYP1B1. Collectively, our results demonstrate that CYP1B1 may reduce the relapse-free survival rate of breast cancer patients by inducing invasive traits in cancer cells via p53 regulation based on the mutation status of TP53 genes and further activation of the uPAR pathway. The elucidation of the previously unknown molecular mechanism of CYP1B1 may provide evidence for the development of effective anti-cancer therapeutic strategies that target the progression of cancer invasion.

Original languageEnglish
Article number166868
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1870
Issue number1
DOIs
StatePublished - Jan 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CYP1B1
  • Invasive traits
  • Phosphorylation
  • Relapse-free survival of breast cancer patients
  • uPAR
  • Wildtype/oncogenic mutant p53

Fingerprint

Dive into the research topics of 'Enhancing the invasive traits of breast cancers by CYP1B1 via regulation of p53 to promote uPAR expression'. Together they form a unique fingerprint.

Cite this